Feb 14 (Reuters)-
Solasia Pharma K. K.
PARENT-ONLY FINANCIAL HIGHLIGHTS
(in billions of yen unless specified)
Year ended Year ended Year to NEXT
Dec 31, 2023 Dec 31, 2022 Dec 31, 2024 YEAR
LATEST YEAR-AGO COMPANY COMPANY
RESULTS RESULTS FORECAST H1 FORECAST
Sales 617 mln 1.09
(-43.5 pct) (+95.5 pct)
Operating loss 688 mln loss 1.70
Recurring loss 678 mln loss 1.77
Net loss 679 mln loss 2.08
EPS loss 4.04 yen loss 13.72 yen
EPS Diluted loss 4.04 yen loss 13.72 yen
NOTE - Solasia Pharma K. K..
To see Company Overview page, click reuters://REALTIME/verb=CompanyData/ric=4597.T